Venus Remedies Ltd

Special Window for re-lodgement of physical share transfers

• Social media posts announce opening of Special Window for re-lodgement of physical share transfers.
• Window aligns with SEBI orders dated July 2, 2025 and January 30, 2026.
• Posts cited on Venus Remedies' official handles (Instagram, Facebook, LinkedIn, X).
• No operational changes or policy updates disclosed in this notice.
• Company Secretary Neha signs off on the communication.

Venus Remedies Ltd board meeting filing shows limited disclosed details

CIN Change and MOA alteration

• CIN changed from L24232CH1989PLC009705 to L21002CH1989PLC009705.
• Change resulted from alteration of object clause and amended MOA approved by Special Resolution on 20 August 2026.
• Certificate of Registration of the Special Resolution confirming alteration and updated CIN issued by MCA.
• Exchanges are requested to update the CIN in the Corporate Information section.

Venus Remedies Ltd: Closure of Trading Window from October 1, 2026 till 48 hours after declaration of unaudited financial results for the period ending September 30, 2026

Special window for re-lodgement of physical share transfers

• Announcement about a special window for re-lodgement of physical share transfer requests.
• Related SEBI notices dated July 2, 2025 and January 30, 2026 referenced.
• No financial impact or governance changes disclosed in this update.

AGM Details

• Date, time, mode: 20 August 2026 at 11:30 AM via VC/OAVM.
• Record date: 13 August 2026.

Key Resolutions

• Ordinary: Receive, consider and adopt standalone financial statements for year ended 31 March 2026.
• Ordinary: Final dividend of Rs 10 per equity share.
• Ordinary: Re-appoint Ashutosh Jain as director by rotation.
• Ordinary: Re-appoint Peeyush Jain as director by rotation.
• Ordinary: Re-appoint Manu Chaudhary as Joint Managing Director for five years.
• Ordinary: Re-appoint Saransh Chaudhary as director for five years.
• Ordinary: Appoint Dr. Gurminder Singh as Non-Executive Independent Director for five years.
• Ordinary: Appoint Dr. Savita Gupta as Non-Executive Independent Director for five years.
• Special: Alter Memorandum of Association.
• Special: Adopt new Articles of Association.

Voting Results

• All resolutions passed with requisite majority.
• No resolution failed; no significant dissent noted.

Dividend

• Final dividend of Rs 10 per equity share approved.

Director Changes

• Re-appoint Ashutosh Jain as director by rotation.
• Re-appoint Peeyush Jain as director by rotation.
• Re-appoint Manu Chaudhary as Joint Managing Director for five years.
• Appoint Saransh Chaudhary as Director for five years.
• Appoint Dr. Gurminder Singh as Non-Executive Independent Director for five years.
• Appoint Dr. Savita Gupta as Non-Executive Independent Director for five years.

Auditors

• Remuneration of cost auditor for financial year 2026-27 ratified.

Material Related Party Transactions

• No material related party transactions disclosed in AGM.

Other Material Approvals

• Special resolutions to alter Memorandum and Articles of Association approved.

Venus Remedies Limited AGM filing chunk contains no extractable details